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Objective: Several studies have reported that polymorphisms on chromosome 9p21.3, near the CDKN2A/2B gene, are
strongly associated with increased susceptibility to abdominal aortic aneurysm (AAA). However, no convincing data has
been reported on a relationship between AAA and these variants in the Chinese Han population. The aim of this study
was to evaluate the role of rs10757278 and rs1333049 in determining genetic susceptibility to AAA.
Methods: A total of 155 AAA patients and 310 controls, comparable in age and gender, were enrolled in this study. DNA
samples were genotyped for rs10757278 and rs1333049 using the MassArray system. The association between these two
single nucleotide polymorphisms and AAAs was tested using multivariate logistic regression. Stratiﬁed analysis was also
performed by clinical and laboratory features.
Results: Single nucleotide polymorphisms rs10757278 and rs1333049 were signiﬁcantly associated with increased risk of
AAA.The frequencies of rs10757278-Gand rs1333049-C inAAApatientswere signiﬁcantly higher than in control subjects
(odds ratio [OR], 1.53; 95% conﬁdence interval [CI], 1.11-2.11; P[ .01, and OR, 1.48; 95% CI, 1.07-2.05; P[ .02).
Multiple logistic regression analysis indicated that, after adjusting for smokinghabits, drinkinghabits, andhistories of other
chronic diseases, homozygosity of the risk allele for rs10758278-G and rs1333049-C also increased the likelihood of AAA
(OR, 2.31; 95% CI, 1.22-4.36, and OR, 2.14; 95% CI, 1.13-4.05). The frequency of the GC haplotype was signiﬁcantly
higher in AAA patients than in control subjects (OR, 1.44; P [ .038). Stratiﬁcation analysis of clinical and laboratory
features revealedno associationbetweenpolymorphisms andaortic diameters inAAApatients.Therewas a signiﬁcantlyhigh
frequency of the rs10757278 GG genotype in AAA patients with high serum total homocysteine compared with those
control subjects with high serum total homocysteine (OR, 2.71; 95% CI, 1.12-6.58; P[ .03) indicating that the genotype
GG of rs10757278 might interact with the homocysteine biological pathway to stimulate the presence of AAA.
Conclusions: Present data demonstrate that rs10757278 and rs1333049 on chromosome 9p21.3 are signiﬁcantly asso-
ciated with increased risk of AAA in the Chinese population and emphasize the need to further study the role of these
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://dx.doi.org/10.1016/j.jvs.2013.10.095Abdominal aortic aneurysm (AAA) is a severe, chronic,
degenerative condition, characterized by segmental weak-
ening and dilation of the aortic wall. There is a strong
genetic component to AAA, with ﬁrst-degree relatives
having a two- to ﬁve-fold increased risk of developing the
disease. Furthermore, interindividual variation in suscepti-
bility to AAA has been shown to be 70% genetic.1,2 The
mode of inheritance of AAA is unknown, although pedi-
gree studies have suggested that AAA is a complex disease
with the risk of AAA development inﬂuenced by an
unknown number of genes that act in combination with
environmental factors.
The chromosome 9p21.3 (Chr9p21.3) locus was
discovered during the ﬁrst surge of the genome-wide asso-
ciation study for cardiovascular disease (CAD) in 2007
with four independent groups simultaneously publishing
its discovery. It was demonstrated that the same variants879
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presence of aneurysms in the abdominal aorta and intracra-
nial arteries.3-6 The Chr9p21.3 region has no known
protein-coding genes; the closest protein-coding genes
are located a few kilobases proximal to this region. These
genes are situated in a cluster and consist of CDKN2A,
ARF, and CDKN2B. In addition, the Chr9p21 region
contains a long intergenic non-coding RNA, designated
antisense noncoding RNA of the INK4 locus, which is
expressed in atherosclerotic tissue as well as in the walls
of AAAs and is regulated by Chr9p21. This could be
a key factor for further understanding the pathophysiology
at the locus.7 Functional studies have demonstrated that
9p21 contributes to atherosclerotic disease by modulating
inﬂammatory pathways, contributing to artery atheromas,
or by inﬂuencing CDKN2A and CDKN2B expression,
which then impacts regulation of cell proliferation, cell
aging, senescence, and apoptosis.8 Despite this data, the
mechanism of the interaction between 9p21 and AAA is
still unknown and requires further investigation.
The variants on Chr9p21 that are associated with AAA,
rs10757278 and rs1333049, are in one linkage disequilib-
rium (LD) block, and rs1333049 has been identiﬁed as
a perfect surrogate (r2 ¼ 1) of rs10757278 in HapMap
CEU samples. Several previous studies of the Chinese pop-
ulation have found that rs10757278 and/or rs1333049 are
correlated with peripheral arterial disease (PAD), myocar-
dial infarction (MI), CAD, and type 2 diabetes.9-11
However, the association between polymorphisms and
the presence or development of AAA in the Chinese Han
population remains largely unexplored.
Although the relationship between variants on
Chr9p21 and AAA has been accepted, most epidemiolog-
ical studies have been carried out in the Caucasian popula-
tion. Due to the huge differences in environment and
genetic background between Caucasians and Chinese, it
is vitally important that the genetic risk factors for AAA
be examined in the Chinese population. Therefore, the
present study was undertaken to explore the association
between the single nucleotide polymorphisms (SNPs)
rs10757278 and rs1333049 and the presence of AAA
and to evaluate the association among patients with
different clinical and laboratory features of AAA patients
in the Chinese Han population.
METHODS
Study site and population. A case-control study was
carried out in China between July 2011 and December
2012. AAA patients (n ¼ 155) who were diagnosed at the
Vascular and Endovascular Surgery Department of the
Chinese PLA General Hospital in Beijing were enrolled.
AAA patients had to be diagnosed with infrarenal AAAs by
abdominal Doppler ultrasound or computed tomography
(CT) and had to be in the perioperative period or under-
going medical therapy. AAA patients were excluded if 1)
they had been diagnosed with inﬂammatory AAA, which
has a different etiology; 2) they had serious, active,
inﬂammatory processes occurring that could lead tohyperpyrexia, which might inﬂuence the predictive value of
biochemical examination parameters; 3) they had any
mental disorders or if they were pregnant.
The control groups included non-AAA participants
who were selected from the same hospital, as well as from
the general population of the same city. Half (n ¼ 155)
of the control subjects were from the Vascular and Endo-
vascular Surgery ward at the Chinese PLA General Hospital
(referred to as control group 1) and half (n ¼ 155)
were from communities in Beijing, including urban and
suburban districts (referred to as control group 2). Control
participants had to be gender and age matched (within
5 years) with AAA patients and had to be negative for
AAA by abdominal Doppler ultrasound. Non-AAA partici-
pants were excluded if (1) they had serious, active, inﬂam-
matory processes or autoimmune diseases leading to
hyperpyrexia; (2) they had any mental disorders or preg-
nant; (3) they had been diagnosed with symptomatic
PAD, such as claudication, rest pain. The main standard
for selecting control participants selection was to enroll
subjects who did not have and any AAA-related diseases,
such as PAD. Therefore, subjects with symptomatic PAD
were excluded via interviews prior to enrollment.
Data collection procedures. An in-person interview
was conducted with each participant using a standardized
questionnaire to collect data related to socio-
demographics, history of chronic diseases and medication,
and lifestyle factors, including cigarette smoking habits,
alcohol consumption, and leisure physical activities.
Participants underwent a standard physical examination
including body temperature, blood pressure, abdominal
ultrasound or CT, and ankle-brachial index examination.
AAA was deﬁned as a maximal infrarenal aortic diameter
$30 mm, and a large AAA was deﬁned as an infrarenal
aortic diameter $55 mm. The maximum diameter of each
AAA was measured at the conventional CT after vascular
surgeons reviewed then entire scan. Two trained ultra-
sound doctors performed abdominal ultrasound examina-
tions on control group participants to exclude AAA. Aortic
diameters were measured in control subjects at the level of
the renal arteries and 1 cm distal to this level. The maximal
inner-inner infrarenal aortic diameter was then measured
and reported. Peripheral venous fasting blood samples were
obtained to detect biochemical parameters and to extract
DNA from leukocytes. Biochemical parameters were
analyzed at the clinical laboratory of the Chinese PLA
Hospital. Informed consent was obtained from all study
participants.
Assessment of major environmental risk factors. In
this study, participants were divided into two groups
according to smoking status (those who never smoked
and smokers), drinking status (almost none and drinkers),
and frequency of leisure activity (almost none or at least
1 day/week). Smoking is considered to be an independent
risk factor for AAA, and subjects were considered to be
smokers if they had smoked more than 100 cigarettes
over their lifetimes. Drinkers were deﬁned as consuming
at least 50 mL of white spirit at a time and having a drink
Table I. Demographic characteristics of abdominal aortic aneurysm (AAA) patients and controls
Variable Case group (n ¼ 155)
Control groups (n ¼ 310)
P2Control group 1 (n ¼ 155) Control group 2 (n ¼ 155) P1
Age, years 69.2 6 10.0 69.6 6 10.9 69.5 6 9.0 .89 .85
Gender, male 138 (89.0) 138 (89.0) 138 (89.0) 1.00 1.00
Smoking habits 132 (85.2) 69 (44.5) 98 (63.2) <.01a <.01a
Drinking habits 79 (51.0) 58 (37.4) 67 (43.2) .30 .02a
Physical activity habits 94 (60.7) 87 (56.1) 108 (69.7) .02a .63
Hypertension 108 (70.0) 64 (41.3) 79 (51.6) .09 <.01a
Dyslipidemia 118 (76.1) 65 (41.9) 73 (47.1) .36 <.01a
Type 2 diabetes 18 (11.6) 27 (17.4) 19 (12.4) .20 .34
CAD 53 (34.2) 36 (23.2) 44 (28.8) .30 .06
Ischemic stroke 29 (18.7) 17 (11.0) 14 (9.2) .57 .01a
PAD 51 (32.9) 22 (14.32) 29 (18.7) .28 <.01a
Aorta diameter, mm 54.2 6 16.1 17.3 6 3.6 16.8 6 2.8 .10 <.01a
tHcy 19.3 (15.4, 26.3) 15.8 (12.2, 21.2) 13.9 (11.2, 20.1) .12 <.01a
CAD, Coronary artery disease; PAD, peripheral occlusive arterial disease; tHcy, serum total homocysteine.
Continuous data are shown as the mean 6 standard deviation or median (lower quantile, upper quantile), and categorical data as number (%).
P1 values were calculated by comparing demographic or clinical characteristics between two control groups and P2 values were calculated by comparing
characteristics between AAA and all controls.
aP < .05 was considered signiﬁcant.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 4 Wei et al 881at least once a week for more than half a year. The histories
of chronic diseases among subjects were self-reported and
included type 2 diabetes, CAD, ischemic stroke, and
symptomatic PAD. Hypertension, hyperlipidemia, and
asymptomatic PAD were diagnosed according to physical
examination results and biochemical laboratory assess-
ments. Hypertension was deﬁned as systolic pressure
$140 mm Hg or diastolic blood pressure $90 mm Hg, or
if the participants were taking hypotensive drugs. Hyper-
lipidemia was deﬁned as a plasma concentration of total
cholesterol >1.7 mmol/L, triglycerides >5.7 mmol/L,
high-density lipoprotein cholesterol <1.0 mmol/L, or if
the participants were taking hypolipidemic drugs. Subjects
were classiﬁed as having PAD when the ankle-brachial index
value was less than 0.9. The concentration of serum total
homocysteine (tHcy) was dichotomized into high tHcy
($15umol/L) and normal tHcy (<15umol/L), as deter-
mined by the laboratory’s reference range.
DNA extraction and genotyping. Two polymor-
phisms on the Chr9p21.3 region were studied. These poly-
morphisms were chosen based on published data indicating
their association with several atherosclerotic diseases, such
as PAD, CAD, and MI.9,12 Genomic DNA was extracted
fromtheperipheral bloodusing the salt fractionationmethod.
The DNA samples were stored at 80C until analyzed.
Polymerase chain reaction was performed on a thermal cycler
(ABI GeneAmp 9700 384 Dual; ABI, Foster City, Calif).
Genotypes were analyzed with Typer 4.0 software (Mas-
sARRAYCompact System; Sequenom, SanDiego, Calif). All
SNPs in this study had a genotyping success rate of >99%.
Statistical analysis. Comparisons of continuous vari-
ables (age, aortic diameter, serum tHcy level) between
patients and controls were performed using the nonpara-
metric Mann-Whitney test. The two SNPs in the 9p21
region were analyzed to determine whether they could
comprise haplotypes in the Chinese population andhaplotype frequencies between case and control subjects
were compared. Hardy-Weinberg equilibrium for each
SNP was tested by the c2 test. Genotypes and risk allele
frequencies of AAA patients were compared with controls
using the c2 test. The adjusted odds ratios (ORs) and 95%
conﬁdence intervals (CIs) for the effect of heterozygous
and homozygous genotypes on the risk of AAA were
estimated by multivariate logistic regression analysis after
adjusting for traditional cardiovascular risk factors, such as
smoking, drinking, hypertension, and dyslipidemia, as well
as the presence of arterial occlusive diseases. All participants
were divided into two subgroups according to serum tHcy
level, and the relationship between polymorphisms and
tHcy serum concentrations was analyzed using logistic
regression.
All statistical analysis was performed using SAS 9.13
software (SAS Institute Inc., Cary, NC). The LD haplotype
was examined using Haploview software (provided in the
public domain, http://www.broadinstitute.org/haploview/
haplovies, version 4.1, April, 2008). The adjusted ORs of
the haplotype were calculated by logistic regression analysis
via PLINK (provided in the public domain, http://pngu.
mgh.harvard.edu/wpurcell/plink, version 1.07, August
2009, accessed March 2011). All statistical tests were
considered to be signiﬁcant at an alpha level of 0.05 on
a two-tailed test.
RESULTS
Subjects. The study included a total of 465 subjects.
Demographic and clinical characteristics of the subjects
are reported in Table I. A total of 155 AAA patients
were enrolled, 138 of which were men (89.0%). The mean
age for AAA patients was 69.2 6 10.0 years, and the mean
abdominal aortic diameter was 54.2 6 16.1 mm. Except
for smoking and leisure physical activity, no differences
were found in the demographic or clinical characteristics
Table II. Allele and genotype frequencies of rs10757278 and rs1333049 polymorphisms in patients and controls
Genotype AAA, No. (%) Control, No. (%)
Crude Adjusteda
OR (95% CI) P OR (95% CI) P
rs10757278
AA 29 (18.7) 82 (26.8) 1.0 (referent) - 1.0 (referent) -
GA 77 (49.7) 156 (51.0) 1.46 (0.89-2.42) .14 1.27 (0.72-2.24) .40
GG 49 (31.6) 68 (22.2) 2.14 (1.22-3.74) .01 2.31 (1.22-4.36) .01
G 175 (56.5) 292 (47.7) 1.42 (1.08-1.87) .01 1.53 (1.11-2.11) .01
rs1333049
GG 31 (20.0) 81 (26.1) 1.0 (referent) - 1.0 (referent) -
CG 75 (48.4) 164 (52.9) 1.20 (0.73-1.96) .48 1.07 (0.61-1.88) .81
CC 49 (31.6) 65 (21.0) 1.97 (1.13-3.43) .02 2.14 (1.13-4.05) .02
C 173 (55.8) 294 (47.5) 1.40 (1.07-1.84) .02 1.48 (1.07-2.05) .02
AAA, Abdominal aortic aneurysm; CI, conﬁdence interval; OR, odds ratio.
aThe adjusted OR, 95% CI, and P value were calculated by comparing the heterozygosity or homozygosity for the risk allele with homozygosity for the
normal allele and risk allele frequency by logistic regression analysis after adjusting for smoking, drinking, and history of other chronic diseases.
Table III. Haplotype analysis of the 9p21.3 region
Haplotype
Case
group freq.
Control
group freq.
Univariate
analysis
Multivar-
iate
analysisa
OR P OR P
Block: rs10757278, rs1333049
GC 0.56 0.48 1.43 .014 1.44 .038
AG 0.44 0.53 0.71 .015 0.71 .025
OR, Odds ratio; PAD, peripheral arterial disease.
aAdjusted for smoking habits, drinking habits, and history of other chronic
diseases (hypertension, hyperlipidemia, type 2 diabetes, coronary heart
disease, ischemic stroke, PAD).
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ulation) suggesting there was internal homogeneity among
participants, thus the data from control subjects was
combined for analysis. As expected, based on selection
criteria, there were no differences in gender and age
between AAA patients and controls. Statistically signiﬁcant
differences were found in traditional cardiovascular risk
factors. Elevated tHcy was found to be signiﬁcantly
different between groups (P < .01).
SNP analysis. There was no signiﬁcant deviation
from Hardy-Weinberg equilibrium for either SNP, in
AAA patients or controls (P > .05). There was no
signiﬁcant difference in the risk allele frequencies of the
two polymorphisms between the two control groups
(rs10757278-G, P ¼ .58 and rs1333049-C; P ¼ .64).
Genotype distribution of the two polymorphisms and the
ORs, 95% CIs and P values of SNPs, estimated by
logistic regression analysis between AAA and controls, are
reported in Table II.
The risk allele frequencies of rs10757278-G and
rs1333049-C were signiﬁcantly different between AAA
patients and controls (rs10757278, OR, 1.53; 95% CI,
1.11-2.11 and rs1333049, OR, 1.48; 95% CI, 1.07-2.05)
after adjusting for traditional cardiovascular disease risk
factors such as smoking, drinking, and history of other
chronic diseases (hypertension, hyperlipidemia, type 2 dia-
betes, CAD, ischemic stroke, and PAD). Homozygosity of
the risk allele with the SNPs rs10758278-G and
rs1333049-C also increased the likelihood for developing
AAA (OR, 2.31; 95% CI, 1.22-4.36, and OR, 2.14; 95%
CI, 1.13-4.05) compared with rs10757278 AA and
rs1333049 GG genotypes.
Haplotype analysis. Rs10757278 and rs1333049
were in obvious LD (D0 ¼ 0.987, r2 ¼ 0.961) within
one block and comprised two haplotypes in this study.
The frequency of the GC haplotype was signiﬁcantly higher
in AAA patients than in control subjects (0.56, 0.48; P ¼
.014). After adjusting for traditional cardiovascular disease
risk factors, the GC haplotype was still occurred signiﬁ-
cantly more frequently in AAA patients than in controlsubjects (OR, 1.44; P ¼ .038), suggesting that those
who carried both the rs10757278-G and rs1333049-C
risk alleles had an approximately 44% higher risk of AAAs
than noncarriers. The frequencies, P values, and ORs for
haplotypes with a frequency greater than 5%, are shown in
Table III.
Stratiﬁed analyses of the association between SNPs
and clinical and laboratory features. The AAA patients
were divided into small AAA or large AAA subgroups
depending on aortic diameter. A total of 91 (58.7%)
patients had large AAAs and 64 (41.3%) patients had small
AAAs. The mean abdominal aortic diameters of small and
large AAAs were 44.2 6 7.0 mm and 68.3 6 14.7 mm,
respectively. As shown in Table IV, the distribution of
neither rs10757278-G nor rs1333049-C was signiﬁcantly
different between patients with small or large AAAs, sug-
gesting that neither of the polymorphisms inﬂuenced aortic
diameter.
All participants were divided into tHcy$15 umol/L or
tHcy <15 umol/L subgroups according to the laboratory
criteria for serological data. The genotype distribution of
the two polymorphisms in the elevated serum tHcy
subgroup is shown in Table V. After adjusting for tradi-
tional cardiovascular disease risk factors, the genotype
GG (vs AA) of rs10757278 was signiﬁcantly more
Table IV. Polymorphisms according to aortic diameters subgroups in abdominal aortic aneurysm (AAA) patients
Genotype Large AAA, No. (%) Small AAA, No. (%)
Crude Adjusteda
OR (95% CI) P OR (95% CI) P
rs10757278
AA 12 (18.8) 17 (18.7) 1 (referent) - 1 (referent) -
GA 30 (46.9) 47 (51.7) 0.90 (0.38-2.16) .82 0.91 (0.35-2.36) .85
GG 22 (34.4) 27 (29.7) 1.15 (0.46-2.92) .76 1.39 (0.49-3.87) .54
rs1333049
GG 13 (20.3) 18 (19.8) 1 (referent) - 1 (referent) -
CG 29 (45.3) 46 (55.6) 0.87 (0.37-2.05) .75 0.84 (0.33-2.13) .71
CC 22 (34.4) 27 (29.7) 1.13 (0.46-2.80) .79 1.30 (0.48-3.57) .61
CI, Conﬁdence interval; OR, odds ratio.
aThe adjusted OR, 95% CI, and P value were calculated by comparing the heterozygosity or homozygosity for the risk allele with homozygosity for the
normal allele by logistic regression analysis after adjusted for age, gender, smoke, drink, and history of other chronic diseases.
Table V. Association between genotypic frequencies and abdominal aortic aneurysms (AAAs) among elevated serum
total homocysteine (tHcy) subgroups
Genotype Case, No. (%) Control, No. (%)
Crude Adjusted a
OR (95% CI) P OR (95% CI) P
rs10757278
AA 19 (16.4) 36 (28.1) 1 (referent) - 1 (referent) -
GA 63 (54.3) 63 (49.2) 2.05 (1.07-3.93) .03 1.85 (0.85-4.02) .12
GG 34 (29.3) 29 (22.7) 2.41 (1.15-5.04) .02 2.71 (1.12-6.58) .03
G 131 (56.5) 121 (47.3) 1.53 (1.06-2.21) .02 1.64 (1.05-2.55) .03
rs1333049
GG 21 (18.1) 36 (27.5) 1 (referent) - 1 (referent) -
CG 61 (52.6) 66 (50.4) 1.58 (0.84-3.01) .16 1.47 (0.68-3.16) .32
CC 34 (29.3) 29 (22.1) 2.01 (0.97-4.18) .06 2.31 (0.96-5.55) .06
C 129 (55.6) 124 (47.3) 1.41 (0.98-2.03) .06 1.52 (0.98-2.36) .06
CI, Conﬁdence interval; OR, odds ratio; PAD, peripheral arterial disease.
aAdjusted by covariates, including age, gender, smoking habit, drinking habit, hypertension, type 2 diabetes, coronary artery disease, ischemic stroke, and
PAD.
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(22.7%; OR, 2.71; 95% CI, 1.12-6.58; P ¼ .03), indicating
that rs10757278-G might inﬂuence tHcy concentration
and interact with the homocysteine biological pathway to
stimulate the presence of AAA.
DISCUSSION
In the present study, two genetic variants, rs10757278
and rs1333049, and their GC haplotype in the Chr9p21
region were identiﬁed for the ﬁrst time as signiﬁcant and
independent risk factors for presence of AAA in the
Chinese Han population. Moreover, we observed that
a signiﬁcantly higher number of AAA patients with high
tHcy levels ($15 umol/L) carried the rs10757278 GG
genotype than did patients with normal tHcy levels, sug-
gesting the possibility that rs10757278-G interacts with
the homocysteine biological pathway.
In the present study, we conﬁrmed an association
between rs10757278, rs1333049, and AAA susceptibility,
which had been reported previously in several other popu-
lations. These polymorphisms had been established as likely
disease-related genetic variants suggestive of increased riskfor AAA in different ethnic groups. In this study, the
frequency of the G allele of rs10757278 was similar to
the frequency of rs1333049-C in control subjects and
was exactly the same as that in the Chinese general popu-
lation (46.8%).13 However, Helgadottir et al6 genotyped
rs10757278 in Icelandic subjects, as well as several addi-
tional case-control sets of European descent, including
subjects from Belgium, Canada, the Netherlands, and
New Zealand, and found signiﬁcant differences among
Caucasians (43.7-52.7%).6,13 These results indicate that,
when evaluating a disease-related gene, it is necessary to
study the genetic associations in different ethnic groups
due to genetic heterogeneity.
Several previous studies in the Chinese Han population
have reported association between haplotypes at the
Chr9p21 region and metabolic syndrome, CAD, especially
PAD, and type 2 diabetes.9,14-16 It has been previously re-
ported that rs10757278 and rs1333049 are in strong LD
in Caucasians.6 In the present study, we found that these
two SNPs were also in strong LD in the Chinese Han pop-
ulation and reported, for the ﬁrst time, a signiﬁcant associ-
ation between the haplotype GC for rs10757278 and
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current study indicate that the chromosome 9p21 region
may harbor the risk loci that confer susceptibility to AAA.
Elevated serum tHcy has been extensively associated
with vascular events, including MI and stroke.17 An associ-
ation between AAA and elevated homocysteine plasma
levels has been reported in several studies.18-20 Halazun
et al21 have found that AAA patients with elevated tHcy
have faster expansion rates compared with patients with
normal tHcy. A positive dose-response relationship
between tHcy levels and abdominal aortic diameter had
been recently reported.22 Although several studies have
failed to demonstrate an association between tHcy and
AAA or aortic diameter,23-25 Liu et al26 performed
a meta-analysis and demonstrated that an increase in
tHcy is associated with risk of AAA. THcy inﬂuences
a range of molecular pathways of potential relevance to
the pathogenesis of AAA, including endothelial dysfunc-
tion and matrix remodeling, as well as inﬂammatory and
immune reactions.26 Therefore, we examined whether
the SNPs, rs10757278 or rs1333049, inﬂuenced serum
concentrations of tHcy. The genotype GG (vs AA) of
rs10757278 was found to be more common in patients
with high tHcy concentrations when compared with
control subjects with elevated tHcy concentrations. These
data imply that polymorphisms on 9p21 might interact
with the homocysteine biological pathway to stimulate
the formation of AAAs. We did not ﬁnd any previous
studies that supported a relationship between these two
polymorphisms and serum tHcy levels. Further studies,
with larger sample sizes, should be conducted to conﬁrm
any association between these polymorphisms and tHcy
levels.
We did not ﬁnd an association between polymorphisms
on Chr9p21.3 and aneurysm diameter, suggesting that this
study may not have been adequate for evaluating the inﬂu-
ence of these polymorphisms on the progression of AAA,
especially since it was not a cohort study. Future studies,
that follow AAA patients for several years, provide a more
accurate evaluation as to whether these polymorphisms
inﬂuence the development and expansion of AAAs.
CONCLUSIONS
The present study has identiﬁed rs10757278 and
rs1333049 as independent genetic risk markers for AAA
in the Chinese population and has underscored the crucial
role of the Chr9p21 region in aneurysmal diseases.
The authors thank all participants for their enrollment
in this study. The authors also thank Shaoping Huang, Na
Li, Yuhua Li and Jianping Guo for helping with the collec-
tion of data.
AUTHOR CONTRIBUTIONS
Conception and design: YH, WG, DC
Analysis and interpretation: YW, JX
Data collection: JX, SZ, FC
Writing the article: YW, JXCritical revision of the article: DC, TW
Final approval of the article: YH, WG
Statistical analysis: YW, DC, TW
Obtained funding: YH, WG
Overall responsibility: YHREFERENCES
1. Larsson E, Granath F, Swedenborg J, Hultgren R. A population-based
case-control study of the familial risk of abdominal aortic aneurysm.
J Vasc Surg 2009;49:47-50.
2. Wahlgren CM, Larsson E, Magnusson PK, Hultgren R, Swedenborg J.
Genetic and environmental contributions to abdominal aortic aneurysm
development in a twin population. J Vasc Surg 2010;51:3-7.
3. Thompson AR, Golledge J, Cooper JA, Hafez H, Norman PE,
Humphries SE. Sequence variant on 9p21 is associated with the pres-
ence of abdominal aortic aneurysm disease but does not have an impact
on aneurysmal expansion. Eur J Hum Genet 2009;17:391-4.
4. Bown MJ, Braund PS, Thompson J, London NJ, Samani NJ,
Sayers RD. Association between the coronary artery disease risk locus
on chromosome 9p21.3 and abdominal aortic aneurysm. Circ Car-
diovasc Genet 2008;1:39-42.
5. Biros E, Cooper M, Palmer LJ, Walker PJ, Norman PE, Golledge J.
Association of an allele on chromosome 9 and abdominal aortic
aneurysm. Atherosclerosis 2010;212:539-42.
6. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S,
Steinthorsdottir V, Manolescu A, et al. The same sequence variant on
9p21 associates with myocardial infarction, abdominal aortic aneurysm
and intracranial aneurysm. Nat Genet 2008;40:217-24.
7. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F,
et al. Susceptibility to coronary artery disease and diabetes is encoded
by distinct, tightly linked SNPs in the ANRIL locus on chromosome
9p. Hum Mol Genet 2008;17:806-14.
8. Motterle A, Pu X, Wood H, Xiao Q, Gor S, Ng FL, et al. Functional
analyses of coronary artery disease associated variation on chromosome
9p21 in vascular smoothmuscle cells. HumMol Genet 2012;21:4021-9.
9. Tian LB, Fang H, Gao L, Tan Z, Zhen YF, Tian JL, et al. 9p21
polymorphisms increase the risk of peripheral artery disease in the Han
Chinese population. J Int Med Res 2013;41:106-14.
10. Qi L, Li JM, Sun H, Huang XQ, Lin KQ, Chu JY, et al. Association
between gene polymorphisms and myocardial infarction in Han
Chinese of Yunnan province. Zhonghua Yi Xue Yi Chuan Xue Za Zhi
2012;29:413-9.
11. Wang W, Peng W, Zhang X, Lu L, Zhang R, Zhang Q, et al.
Chromosome 9p21.3 polymorphism in a Chinese Han population is
associated with angiographic coronary plaque progression in non-
diabetic but not in type 2 diabetic patients. Cardiovasc Diabetol
2010;9:33.
12. Takeuchi F, Yokota M, Yamamoto K, Nakashima E, Katsuya T,
Asano H, et al. Genome-wide association study of coronary artery
disease in the Japanese. Eur J Hum Genet 2012;20:333-40.
13. Xie F, Chu X, Wu H, Sun W, Shen M, Yang L, et al. Replication of
putative susceptibility loci from genome-wide association studies asso-
ciated with coronary atherosclerosis in Chinese Han population. PLoS
One 2011;6:e20833.
14. Bayoglu B, Cakmak HA, Yuksel H, Can G, Karadag B, Ulutin T, et al.
Chromosome 9p21 rs10757278 polymorphism is associated with the
risk of metabolic syndrome. Mol Cell Biochem 2013;379:77-85.
15. Fan M, Dandona S, McPherson R, Allayee H, Hazen SL, Wells GA,
et al. Two chromosome 9p21 haplotype blocks distinguish between
coronary artery disease and myocardial infarction risk. Circ Cardiovasc
Genet 2013;6:372-80.
16. Cheng X, Shi L, Nie S, Wang F, Li X, Xu C, et al. The same
chromosome 9p21.3 locus is associated with type 2 diabetes and
coronary artery disease in a Chinese Han population. Diabetes
2011;60:680-4.
17. Wald DS, Morris J, Wald NJ. Reconciling the evidence on serum
homocysteine and ischaemic heart disease: a meta-analysis. PLoS One
2011;6:e16473.
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 4 Wei et al 88518. Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, et al.
High prevalence of mild hyperhomocysteinemia in patients with
abdominal aortic aneurysm. J Vasc Surg 2000;32:531-6.
19. Warsi AA, Davies B, Morris-Stiff G, Hullin D, Lewis MH. Abdominal
aortic aneurysm and its correlation to plasma homocysteine, and vita-
mins. Eur J Vasc Endovasc Surg 2004;27:75-9.
20. Soﬁ F, Marcucci R, Giusti B, Pratesi G, Lari B, Sestini I, et al. High
levels of homocysteine, lipoprotein (a) and plasminogen activator
inhibitor-1 are present in patients with abdominal aortic aneurysm.
Thromb Haemost 2005;94:1094-8.
21. Halazun KJ, Bofkin KA, Asthana S, Evans C, Henderson M, Spark JI.
Hyperhomocysteinaemia is associated with the rate of abdominal aortic
aneurysm expansion. Eur J Vasc Endovasc Surg 2007;33:391-4;
discussion: 395-6.
22. Wong YY, Golledge J, Flicker L, McCaul KA, Hankey GJ, van
Bockxmeer FM, et al. Plasma total homocysteine is associated with
abdominal aortic aneurysm and aortic diameter in older men. J Vasc
Surg 2013;58:364-70.23. Peeters AC, van Landeghem BA, Graafsma SJ, Kranendonk SE,
Hermus AR, Bllom HJ, et al. Low vitamin B6, and not plasma
homocysteine concentration, as risk factor for abdominal aortic aneu-
rysm: a retrospective case-control study. J Vasc Surg 2007;45:701-5.
24. Arapoglou V, Kondi-Paﬁti A, Rizos D, Kotsis T, Kalkandis C,
Katsenis K. The inﬂuence of total plasma homocysteine and traditional
atherosclerotic risk factors on degree of abdominal aortic aneurysm
tissue inﬂammation. Vasc Endovascular Surg 2009;43:473-9.
25. Laughlin GA, Allison MA, Jensky NE, Aboyans V, Wong ND,
Detrano R, et al. Abdominal aortic diameter and vascular atheroscle-
rosis: the Multi-Ethnic Study of Atherosclerosis. Eur J Vasc Endovasc
Surg 2011;41:481-7.
26. Liu Z, Luo H, Zhang L, Huang Y, Liu B, Ma K, et al. Hyper-
homocysteinemia exaggerates adventitial inﬂammation and angiotensin
II-induced abdominal aortic aneurysm in mice. Circ Res 2012;111:
1261-73.
Submitted Aug 6, 2013; accepted Oct 23, 2013.
